Chemoinformaics analysis of Cyclohexanone, 2-[(4-methoxyphenyl)methylene]-
| Molecular Weight | 216.28 | nRot | 2 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 14 |
| Exact Molecular Weight | 216.115 | nRing | 2 |
| Solubility: LogS | -3.992 | nHRing | 0 |
| Solubility: LogP | 3.113 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 35.6527 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.709 |
| Synth | 1.95 |
| Natural Product Likeliness | -0.192 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.922 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.648 |
| MDCK | 0.0000181 |
| BBB | 0.926 |
| PPB | 0.934989 |
| VDSS | 0.525 |
| FU | 0.0434313 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.947 |
| CYP2c19-inh | 0.871 |
| CYP2c19-sub | 0.446 |
| CYP2c9-inh | 0.597 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.602 |
| CYP2d6-sub | 0.89 |
| CYP3a4-inh | 0.372 |
| CYP3a4-sub | 0.367 |
| CL | 6.848 |
| T12 | 0.504 |
| hERG | 0.067 |
| Ames | 0.304 |
| ROA | 0.193 |
| SkinSen | 0.96 |
| Carcinogencity | 0.822 |
| EI | 0.946 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.096 |
| Antiviral | No |
| Prediction | 0.527551 |